News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
News|Slideshows|July 31, 2025

July Pharmaceutical Industry Movers & Shakers

Author(s)Don Tracy, Associate Editor

A monthly roundup of business and people news in the pharmaceutical industry.

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Stock.adobe.com

Marty Makary Out as FDA Commissioner: Report

ByMike Hollan
May 12th 2026
Boehringer Ingelheim’s growing pipeline in autoimmune and inflammatory diseases and builds on a series of recent partnerships in this therapeutic area. Credit: Stock.Adobe.com/Jerome

Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal

ByPE Staff
May 12th 2026
merger and acquisition business concept, join puzzle 3d | Image credit: © nespix - © nespix - stock.adobe.com

Bristol Myers Squibb, Hengrui Pharma Form $15.2 Billion Strategic Drug Development Collaboration

ByFeliza Mirasol
May 12th 2026
Matt Flora, Jamie Singer, FTI Consulting

Pharmaceutical Cybersecurity and Risk Management: Q&A with Jamie Singer & Matt Flora

ByNicholas Jacobus,Jamie Singer ,Matt Flora
May 12th 2026
Janice MacLennan, founder & CEO, Nmblr

The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff

ByNicholas Jacobus,Janice MacLennan
May 12th 2026
Advertisement
Advertisement

Trending on PharmExec

1

The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff

2

President Trump Planning to Fire FDA Commissioner Marty Makary: Report

3

Marty Makary Out as FDA Commissioner: Report

4

From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box

5

GSK Enters Exclusive Collaboration with SBP Group to Accelerate Bepirovirsen at Launch in Mainland China

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us